Adverse Outcomes, Healthcare Resource Utilization, and Costs Associated with Systemic Corticosteroid use Among Adults with Systemic Lupus Erythematosus in the UK

Adverse Outcomes, Healthcare Resource Utilization, and Costs Associated with Systemic Corticosteroid use Among Adults with Systemic Lupus Erythematosus in the UK

Abstract Introduction This analysis was conducted to assess the incidence of adverse clinical outcomes, healthcare resource use (HCRU), and the costs associated with systemic corticosteroid (SCS) use in adults with systemic lupus erythematosus (SLE) in the UK. Methods We identified incident SLE case...

Full description

Bibliographic Details
Main Authors: Heide A. Stirnadel-Farrant, Sarowar M. Golam, Barbara Naisbett-Groet, Danny Gibson, Julia Langham, Sue Langham, Mihail Samnaliev
Format: Article
Language:English
Published: Adis, Springer Healthcare 2023-07-01
Series:Rheumatology and Therapy
Subjects:
Adverse effect
Corticosteroid
Cost
Healthcare resource use
National Health Service
Systemic lupus erythematosus
Online Access:https://doi.org/10.1007/s40744-023-00566-w

Internet

https://doi.org/10.1007/s40744-023-00566-w

Similar Items